Unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world study

Deodhar, A, Strand, V, Conaghan, P orcid.org/0000-0002-3478-5665 et al. (6 more authors) (2020) Unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world study. BMC Rheumatology, 4 (1). 19. ISSN 2520-1026

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s). 2020 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Keywords: Ankylosing spondylitis, DMARD, Quality of life, Tumour necrosis factor-alpha, Treatment failure
Dates:
  • Accepted: 5 February 2020
  • Published (online): 2 March 2020
  • Published: December 2020
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Musculoskeletal Medicine & Imaging (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 11 Feb 2020 11:21
Last Modified: 20 Mar 2020 09:47
Status: Published
Publisher: BMC
Identification Number: https://doi.org/10.1186/s41927-020-0118-z

Share / Export

Statistics